(Press-News.org) Putnam Valley, NY. (Oct. 1, 2012) – A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within 72 hours of the stroke.
Their study is published in the current issue of Cell Transplantation (21:6), now freely available on-line at: http://www.ingentaconnect.com/content/cog/ct/.
"Ischemic stroke is one of the most frequent causes of death and the most common reason for permanent disabilities in adults in industrialized nations," said Dr. Johannes Boltze, study corresponding-author from the University of Leipzig. "Despite recent research, treatment opportunities are limited and the only approved therapy to date must be administered within a narrow four and a half hour time window."
According to the authors there is a "strong demand for alternative strategies," and among those most recently studied is Cell Transplantation using neonatal or adult stem cells. Their study investigates the time-dependent efficacy of hUCB MNCs following experimental brain ischemia in rats. The emphasis of their study was exploring factors that impact on Cell Transplantation to derive the best outcomes, such as determining an appropriate transplantation time point, or window of opportunity.
The researchers transplanted hUCB MNCs into test animals at various time intervals following stroke, at four hours, 24 hours, 72 hours, 120 hours and at 14 days.
"Our results demonstrated that transplantation within a 72 hour time window resulted in an early improvement in functional recovery," said Dr. Boltze. "The failure to induce sustained functional recovery, lesion reduction, and limitation of glial scaring in animals treated at 120 hours indicates the 72 hour time window as efficient for cell application."
The authors noted that administration of hUCB MNCs within the 72 hour window resulted not only in functional recovery but also a reduction in brain atrophy and in diminished glial scaring demonstrating the importance of this factor on the impact of umbilical cord blood Cell Transplantation. Later transplantation, at 14 days, showed no benefit.
"Our study shows that hUCB MNCs are a promising tool for acute stroke treatment, but require a comparatively early intervention in the subacute phase of stroke," concluded the authors.
"This research adds to a growing body of evidence supporting specific early time periods for repair of the brain, spinal cord, heart and other organs following acute injury and is very important in the development of regenerative therapies" said Dr. Paul R. Sanberg, Distinguished Professor of Neurosurgery and Brain Repair at the University of South Florida.
###
Contact: Dr. Johannes Boltze, Frauhofer-Institute for cell Therapy and Immunology, Perlickstr. 1, D-04103 Leipzig, Germany.
Tel. +49-341-97-25814
Fax. +49-341- 97-25829
Email: johannes.boltze@izi.fraunhofer.de
Citation: Boltze, J.; Schmidt, U. R.; Reich, D. M.; Kranz, A.; Reymann, K. G.; Strassburger, M.; Lobsien, D.; Wagner, D.-C.; Förschler, A.; Schäbitz, W.-R. Determination of the Therapeutic Time Window for Human Umbilical Cord Blood Mononuclear Cell Transplantation Following Experimental Stroke in Rats. Cell Transplant. 21(6):1199-1211; 2012.
The Coeditor-in-chief's for Cell Transplantation are at the Diabetes Research Institute, University of Miami Miller School of Medicine and Center for Neuropsychiatry, China Medical University Hospital, TaiChung, Taiwan. Contact, Camillo Ricordi, MD at ricordi@miami.edu or Shinn-Zong Lin, MD, PhD at shinnzong@yahoo.com.tw or David Eve, PhD at celltransplantation@gmail.com
News release by Florida Science Communications www.sciencescribe.net
Therapeutic time window important factor for cord blood cell transplantation after stoke
2012-10-01
ELSE PRESS RELEASES FROM THIS DATE:
MRI images transplanted islet cells with help of positively charged nanoparticles
2012-10-01
Tampa, Fla. (Oct. 1, 2012) – In a study to investigate the detection by MRI of six kinds of positively-charged magnetic iron oxide nanoparticles designed to help monitor transplanted islet cells, a team of Japanese researchers found that the charged nanoparticles they developed transduced into cells and could be visualized by MRI while three kinds of commercially available nanoparticles used for controls could not.
The study is published in a recent special issue of Cell Medicine [3(1)], now freely available on-line at: http://www.ingentaconnect.com/content/cog/cm.
"Our ...
Low birth weight may increase risk for cardiovascular disease, kidney disease and diabetes
2012-10-01
Bethesda, MD— Being underweight at birth may have consequences above and beyond the known short-term effects says a research report published in the October 2012 issue of The FASEB Journal. The report shows that rats with a low birth weight have an increased long-term risk for developing cardiovascular disease, kidney disease, and diabetes. What's more, older females are at higher risk of developing high blood pressure before and during pregnancy, which in turn, may restrict growth in the womb, putting offspring at risk for being born at a low birth weight.
"Ensuring ...
Biological markers increase clinical trial success rate of new breast cancer drugs
2012-10-01
Using biological markers--genetic characteristics that are associated with some patients with breast cancer--can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.
"It's been increasingly difficult for pharmaceutical companies to bring new drugs to market," says Jayson Parker, a faculty member in the Department of Biology and medical biotechnology analyst at the University of Toronto. "On average, about 80 per cent of drugs fail at some point in the clinical trial process."
There ...
Genetically engineered immune system fights melanoma
2012-10-01
MAYWOOD, Il. - Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma treatment that genetically engineers a patient's immune system to fight the deadly cancer.
A batch of the immune system's killer T cells will be removed from the patient and genetically modified in a Loyola lab. Two genes will be inserted into the T cells so that they will recognize tumor cells as abnormal.
The patient will undergo high-dose chemotherapy to kill most of his or her remaining T cells. This will make room for the genetically modified ...
AGU journal highlights -- 1 October 2012
2012-10-01
The following highlights summarize research papers that have been recently
published in Geophysical Research Letters (GRL), Journal of Geophysical
Research - Solid Earth (JGR-B), Journal of Geophysical Research - Oceans
(JGR-C), and Water Resources Research (WRR).
In this release:
1. The pros and cons of trading water: A case study in Australia
2. Linking typhoon tracks with rainfall patterns and flood timing
3. Novel observations of currents and drag generated by a tsunami
4. More water stored along major rivers during El Nino years
5. Model suggests Earth ...
New insights on control of pituitary hormone outside of brain has implications for breast cancer
2012-10-01
PHILADELPHIA - The hormone prolactin is produced by the pituitary gland in the brain and then travels via the bloodstream to cells throughout the body, where it exerts multiple reproductive and metabolic effects, most notably on the breast where it is the master regulator of lactation. In recent years researchers have found that prolactin is also produced by some tissues outside the brain, however little is known about the functions of extra-pituitary prolactin or how its production is regulated in these tissues.
Now, the laboratory of Lewis A. Chodosh, MD, PhD, chair ...
Fish getting smaller as the oceans warm: UBC research
2012-10-01
Changes in ocean and climate systems could lead to smaller fish, according to a new study led by fisheries scientists at the University of British Columbia.
The study, published today in the journal Nature Climate Change, provides the first-ever global projection of the potential reduction in the maximum size of fish in a warmer and less-oxygenated ocean.
The researchers used computer modeling to study more than 600 species of fish from oceans around the world and found that the maximum body weight they can reach could decline by 14-20 per cent between years 2000 and ...
Researchers discover key mechanism for controlling the body's inflammatory response
2012-10-01
Researchers at Queen Mary, University of London have discovered how a key molecule controls the body's inflammatory responses. The molecule, known as p110delta, fine-tunes inflammation to avoid excessive reactions that can damage the organism. The findings, published in Nature Immunology today (30 September), could be exploited in vaccine development and new cancer therapies.
A healthy immune system reacts to danger signals – from microorganisms such as bacteria and viruses, or from the body's own rogue cells, such as cancer cells. This tightly controlled reaction starts ...
Researchers discover gene that causes deafness
2012-10-01
CINCINNATI—Researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have found a new genetic mutation responsible for deafness and hearing loss associated with Usher syndrome type 1.
These findings, published in the Sept. 30 advance online edition of the journal Nature Genetics, could help researchers develop new therapeutic targets for those at risk for this syndrome.
Partners in the study included the National Institute on Deafness and other Communication Disorders (NIDCD), Baylor College of Medicine and the University of ...
New pathogen epidemic identified in sub-Saharan Africa
2012-10-01
A new study out today (Sunday 30 September) reveals that the emergence and spread of a rapidly evolving invasive intestinal disease, that has a significant mortality rate (up to 45%) in infected people in sub-Saharan Africa, seems to have been potentiated by the HIV epidemic in Africa.
The team found that invasive non-Typhoidal Salmonella (iNTS) disease is caused by a new form of the bacteria Salmonella Typhimurium that has spread from two different focal hubs in Southern and Central Africa beginning 52 and 35 years ago, respectively. They also found that one of the ...